ASCO: Roche, head held high, details oral SERD's first-line flop in breast cancer.
Saved in:
| Title: | ASCO: Roche, head held high, details oral SERD's first-line flop in breast cancer. |
|---|---|
| Authors: | Liu, Angus (AUTHOR) |
| Source: | FierceBiotech. 6/2/2026, pN.PAG-N.PAG. 1p. |
| Database: | Business Source Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| Description not available. |
